Real world data supporting identification of the pharmacist’s role in obesity and overweight treatment in Poland – a preliminary report
DOI:
https://doi.org/10.15584/ejcem.2017.3.2Keywords:
overweight, obesity, pharmaceutical care, treatment, real world dataAbstract
Introduction. Obesity is a significant health and economic problem, both for the patient and the health care system. An essential element in the prevention and treatment of each disease is the engagement of all groups of healthcare professionals.
Aim. In our study, we performed an analysis of the real world data, obtained from a survey of the medical and socioeconomic problems associated with overweight and obesity. We aimed to identify the pharmacist’s role in the management of overweight and obese patients, including their individualized education in an outpatient setting.
Material and methods. The study material consisted of responses obtained from a specially designed questionnaire. Our findings indicate that the study patients had easy access to a pharmacist’s professional knowledge, relevant to comprehensive treatment of obesity. In addition, our data indicates a lack of patient knowledge of a healthy lifestyle and an inability to implement such knowledge in practice.
Results. The community pharmacist should actively provide support to patients with obesity (including the primary obesity and those who want to lose excessive body mass for health-related and also for aesthetic reasons) and the management of their weight. The results of our study should be considered as an introduction to further research to facilitate the understanding of problems and expectations of patients and to prepare pharmacists to perform pharmaceutical care (PC) in this regard.
Conclusion. One of the potential options to protect society against the obesity epidemic is an education about the risks inherent to obesity and promotion of a healthy lifestyle.
Downloads
References
World Health Organization web site. www.who.int. Obesity and overweight. Accessed July 1, 2017.
Biuletyn Wydziału Farmaceutycznego AMW. www.biuletynfarmacji.wum.edu.pl/0301Suchocka.html. Suchocka Z. Otyłość. Przyczyny i leczenie. Accessed October 21, 2014.
Co to jest otyłość”. www.zdrowie.med.pl/nadwaga/otylosc_01.html, Accessed February 2, 2015.
World Health Organization website. http://www.who.int/topics/obesity/en/. Obesity. Accessed July 7, 2017.
NutriLife web site. www.NutriLife.plNowacka N. Metody oceny sposobu żywienia i stanu odżywienia. Accessed January 22, 2013.
Platek SM, Singh D. Optimal waist-to-hip ratios in women activate neural reward centers in men. PLoS One. 2010;5(2). DOI: 10.1371/journal.pone.0009042
Gawlik A, Zachurzok-Buczyńska A, Małecka-Tendera E. Powikłania otyłości u dzieci i młodzieży. Via Medica. 2009;19-27.
Mazur A, Klimek K, Telega G, Filip R, Małecka-Tendera E. Ten-year secular trend of overweight and obesity in school children in south-eastern Poland. AAEM. 2014;21(3):634-638.
Przegląd Kardiodiabetologiczny. www.termedia.pl/Czasopismo/Przeglad_Kardiodiabetologiczny-47/Streszczenie-12227. Owecki M. Otyłość epidemią XXI wieku. Accessed November 26, 2016.
Mediweb. www.mediweb.pl/diseases/wyswietl_vad.php?id= 570. Kowalczyk B. Przyczyny otyłości. Accessed September 18, 2016.
Punkt Zdrowia. www.punktzdrowia.pl/choroby-i-dolegliwosci/skutki-otylosci. Krawczyk P. Skutki otyłości. Accessed September 28, 2016.
Aktywnie po zdrowie. www.aktywniepozdrowie.pl/ wszystko-o-otylosci/powiklania-otylosci. Tausig A. Powikłania otyłości. Accessed October 15, 2016.
IASO/IOTF International Association for the Study of Obesity/International Obesity Task Force. www.iaso.org/iotf/obesity/obesitytheglobalepidemic. Accessed July 11, 2016.
World Obesity Federation. International Association for the Study of Obesity/ International Obesity Task Force: Obesity prevalence worldwide – Adults. http://www.worldobesity.org/data/map/overview-adults, Accessed July 3, 2017.
Kwagyan J, Retta TM, Ketete M, et al. Obesity and Cardiovascular Diseases in a High-Risk Population: Evidence-Based Approach to CHD Risk Reduction. Ethn Dis. 2015;25(2):208-213.
Brown TJ, Todd A, O’Malley CL, et al. Community pharmacy interventions for public health priorities: a systematic review of community pharmacy-delivered smoking, alcohol and weight management interventions. Public Health Research. 2016;4(2).
Abramczyk A. Body mass, behaviours and social/health situation in diabetes patients at the level of primary medical healthcare: a Polish national study. Kardiol Pol. 2013;71(5):493–501.
Wojtyła-Buciora P, Stawińska-Witoszyńska B, Klimberg A, et al. Nutrition-related health behaviours and prevalence of overweight and obesity among Polish children and adolescents. Ann Agric Environ Med. 2013;20(2): 332–340.
Babey SH, Wolstein J, Diamant AL. Role models and social supports related to adolescent physical activity and overweight/obesity. Policy Brief UCLA Cent Health Policy Res. 2015;3:1-8.
Pietruszka B. Fizjologia procesów starzenia się w aspekcie potrzeb żywieniowych. In: Gawęcki J, Roszkowski W, ed. Żywienie u progu i schyłku życia. Poznań: Wyd. Uniwersytetu Przyrodniczego w Poznaniu;2013:103-115.
Shcherbakova MY, Vlasova AV, Rozhivanova TA. The role of the intestine microbiota in the development of obesity. Eksp Klin Gastroenterol. 2015;2:11-16.
Rautiainen S, Wang L, Lee IM, Manson J, Buring JE, Sesso HD. Higher Intake of Fruit, but Not Vegetables or Fiber, at Baseline Is Associated with Lower Risk of Becoming Overweight or Obese in Middle-Aged and Older Women of Normal BMI at Baseline. J Nutr. 2015;145(5):960-968.
Dietz WH, Baur LA, Hall K, et al. Management of obesity: improvement of health-care training and systems for prevention and care. Lancet. 2015;385:2521–2533.
Szyndler A, Chrostowska M, Narkiewicz M. Modyfikacja stylu życia jako podstawa leczenia otyłości. Kardiol na co Dzień. 2007; 3 (2): 84–88.
Panas M, Brandys J. Otyłość a stan zdrowia człowieka. Rola farmaceuty w terapii otyłości. In: Jachowicz R, ed. Farmacja praktyczna. Warszawa: PZWL;2007.
Murphy AL, Gardner DM. A scoping review of weight bias by community pharmacists towards people with obesity and mental illness. Can Pharm J (Ott). 2016; 149(4):226–235.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
